Program

Oncobell 4th International Symposium Program

"Novel avenues in cancer prevention, diagnosis and treatment"

Barcelona, March 11th - 12th, 2027. Auditorium, Bellvitge University Hospital.
THURSDAY MARCH 11TH

08.30 – 09.00 REGISTRATION

09.00 – 09.10 WELCOME AND INTRODUCTION

Gabriel Capellá, Director of Institut d’Investigació Biomedica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat.

09.10h – 10.00h OPENING KEYNOTE LECTURE

Giuseppe Curigliano, ESMO President, Milano.

10.00 – 10.30 COFFE BREAK

10.00 – 12.30 SESSION I: TUMOR PREVENTION, INITIATION AND PROGRESSION

Chair:

Conxi Lázaro & Victor Moreno, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat.

10.30 – 11.00 TITLE

Omar S. M. El Nahhas, Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, Germany.

11.00 – 11.30 TITLE

Arkaitz Carracedo, CIC BioGUNE, Pais Vasco, Spain.

11.30 – 12.30 TITLE

Isabel Fabregat, Institut d’Investigació Biomedica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat.

12.00 – 12.30 SELECTED ABSTRACTS – SHORT TALKS

12.30 – 14.00 POSTER SESSION & LUNCH BREAK

14.00 – 16.00 SESSION II: TUMOR HETEROGENEITY AND PLASTICITY 

Chair:

Elisa Espinet & Jordi Bruna, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat.

14.00 – 14.30 TITLE

Maria Casanova, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid.

14.30 – 15.00 TITLE

Leila Akkari, The Netherlands Cancer Institute, Amsterdam, Netherlands.

15.00 – 15.30 TITLE

Antonio Gentilella, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat.

15.30 – 16.00 SELECTED ABSTRACTS – SHORT TALKS

16.00 – 16.30 COFFE BREAK

16.30 – 17.30 ROUNDTABLE: BIOLOGY AND MEDICINE OF CANCER PREVENTION

Chair:

Miguel Angel Genestar Pujana, Institut Català d’Oncologia (ICO), Hospital Duran i Reynals, L’Hospitalet de Llobregat.

Panelists:

Nuria Lopez Bigas, Institute for Research in Biomedicine, IRB Barcelona.

TBD – Asociación Española Contra el Cáncer (AECC).

TBD – Recipient of the 2026 AECC, Biology and Medicine of Cancer Award.

20.00 SPEAKER’S DINNER

FRIDAY MARCH 12TH

09.00 – 11.00 SESSION III: ADCs, GTPase INHIBITORS AND OTHER INNOVATIVE THERAPIES AND COMBINATIONS IN SOLID TUMORS

Chair:

Meritxell Rovira & Agostina Stradella, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL) & Institut Català d’Oncologia (ICO), Hospital Duran i Reynals, L’Hospitalet de Llobregat.

09.00 – 10.00 Targeting KRAS

Colin Lindsay, Department of Medical Oncology, University of Manchester, UK.

09.30 – 10.00 TITLE

Ramon Salazar, Institut Català d’Oncologia (ICO), Hospital Duran i Reynals, L’Hospitalet de Llobregat.

10.00 – 10.30 ADCs in breast cancer

Barbara Pistilli, Medical Oncology Department, Gustave Roussy, Villejuif, France.

10.30 – 11.00 ADCs in lung cancer

Noemí Reguart, Medical Oncology, Hospital Clínic, Barcelona.

11.00 – 11.30 COFFE BREAK

11.30 – 12.30 ROUNDTABLE: Challenges in New Drug Developmental therapeutics

Chair:

Sonia Pernas & Ernest Nadal, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL) & Institut Català d’Oncologia (ICO), Hospital Duran i Reynals, L’Hospitalet de Llobregat.

Panelists:

Jordi Rodón, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston.

Anna Peiró, Oncology Medical Director, AstraZeneca, Madrid.

Michael Lahn, Chief Medical Officer at iOnctura SA, Genève, Switzerland.

PharmaMar, Madrid.

12.30 – 14.00 POSTER SESSION & LUNCH BREAK

14.00 – 16.00 SESSION IV: ADVANCED IMMUNOTHERAPIES

Chair:

Josep Maria Piulats & Lourdes Farré, Institut Català d’Oncologia (ICO), Hospital Duran i Reynals & Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat.

14.00 – 14.30 Glycocheckpoints: beyond the PD1-pdL1 axis

Gabriel Rabinovich, CaixaResearch Institute, Barcelona.

14.30 – 15.00 TITLE

Luis Álvarez-Vallina, Hospital del Mar Research Institute Barcelona (HMRIB), Banc de Sang i Teixits (BST), Barcelona.

15.00 – 15.30 TITLE

Juan José Rojas, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat.

15.30 – 16.00 SELECTED ABSTRACTS – SHORT TALKS

16.00h – 17.00h CLOSING KEYNOTE LECTURE

Francisca Vazquez, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

17.00 – 17.15 CONCLUDING REMARKS